REJURAN i (blister)
Ref M2-002Model REJURAN, REJURAN i, REJURAN s, M2-001, M2-002, M2-003
Active
CE MDR
Valid until
12 Dec 2029
FDA recalls
Not applicable
Documents
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDR | Number0880005100M148257G 08800051001634 | Date3 Dec 2025 | StatusActive |
Certificates
- 2024-AXVI/QS-001/A Active
Quality management system EU MDR
- Certifier
- 3EC International a.s. 2265
- Issued
- 11 Nov 2025
- Expires
- 12 Dec 2029
- 2024-AXVI/TD-001/A Active
Technical documentation EU MDR
- Certifier
- 3EC International a.s. 2265
- Issued
- 11 Nov 2025
- Expires
- 12 Dec 2029
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/MDR Active
Specification
- Device Name
- Rejuran
- Model / Reference
- REJURAN, REJURAN i, REJURAN s, M2-001, M2-002, M2-003
- Primary DI / UDI-DI
- 08800051001634
- Basic UDI-DI
- 0880005100M148257G
- Direct Marketing DI
- 08800051001634
- EMDN Code
- P900402 Resorbable filling and reconstruction devices
- Device Class
- Class III
- EU market of registration
- France
Manufacturer details
- EUDAMED SRN
- KR-MF-000031646
- Authorised representative
- Obelis s.a. BE-AR-000000106
Other devices from PharmaResearch Co., Ltd.
Properties
Other properties (10)
- Reusable: No
- Contains Latex: No
- Reprocessed: No
- CMR Substance: No
- Human-derived: No
- Human Tissues: No
- Endocrine Disruptor: No
- Administering Medicine: No
- Measuring Function: No
- Incorporates Medicinal Product: No